Pages that link to "Q28578378"

The following pages link to Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells (Q28578378):

Displaying 37 items.

• Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts (Q26745566) (← links)
• Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step (Q26771518) (← links)
• The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells (Q28293417) (← links)
• 3-hydroxy-3-methylglutaryl-CoA reductase (Q28562064) (← links)
• Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase (Q28582593) (← links)
• Statins in liver disease: a molehill, an iceberg, or neither? (Q30446668) (← links)
• Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells. (Q33323649) (← links)
• Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability (Q34395409) (← links)
• Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells (Q34737702) (← links)
• Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis (Q35009517) (← links)
• Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study (Q35901096) (← links)
• Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats (Q36541169) (← links)
• Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis (Q36663065) (← links)
• Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes (Q37179559) (← links)
• Simvastatin protects against the development of endometriosis in a nude mouse model (Q37257551) (← links)
• Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat. (Q37404727) (← links)
• Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention (Q37828318) (← links)
• Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects (Q38656007) (← links)
• Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells (Q38819131) (← links)
• Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis. (Q39775427) (← links)
• Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study. (Q40062896) (← links)
• Role for hedgehog signaling in hepatic stellate cell activation and viability (Q40371810) (← links)
• Statin therapy and serum transaminases among a cohort of HCV-infected veterans (Q41345786) (← links)
• Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells (Q41980364) (← links)
• The Effects of Combined Treatment with an HMG-CoA Reductase Inhibitor and PPARγ Agonist on the Activation of Rat Pancreatic Stellate Cells (Q41995936) (← links)
• Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C. (Q42282775) (← links)
• Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats (Q43244751) (← links)
• Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet (Q43845439) (← links)
• Simvastatin activates Keap1/Nrf2 signaling in rat liver (Q46371968) (← links)
• The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis. (Q46911221) (← links)
• Simvastatin augments activation of liver regeneration through attenuating transforming growth factor-β1 induced-apoptosis in obstructive jaundice rats (Q47334982) (← links)
• KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins (Q48246049) (← links)
• Statins improve NASH via inhibition of RhoA and Ras. (Q48352117) (← links)
• Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice (Q51479885) (← links)
• Managing portal hypertension in patients with liver cirrhosis. (Q55278061) (← links)
• HSC-specific knockdown of GGPPS alleviated CCl-induced chronic liver fibrosis through mediating RhoA/Rock pathway (Q64111571) (← links)
• Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats (Q84789545) (← links)